FIRST RUSSIAN EXPERIENCE OF USING THE INTEGRATED SYSTEM OF LASER THERMOABLATION THERAPY IN THE TREATMENT OF METASTATIC LIVER CANCER
https://doi.org/10.17709/2409-2231-2017-4-3-10
Abstract
Extensive liver resections are the main method of treatment of patients with primary and metastatic liver cancer, which allows the noticeable prolongation of life. In patients with a reduced functional reserve of the liver or a missing volume of the remaining liver parenchyma, these interventions become impossible because of the increased risk of postresectional acute hepatic insufficiency. One of the most modern and promising ways to overcome this obstacle is the use of minimally invasive methods of tumor destruction. This article presents two observations of the clinical application of the laser ablator “Echolaser X4”: open laser ablation of the metastatic focus with subsequent atypical liver resection and percutaneous laser ablation of the metastasis of the neuroendocrine tumor into the liver. The presented experience testifies to the justification of using laser destruction of metastatic malignant liver tumors and demonstrates the possibilities of laser thermoablation therapy in patients who can not perform radical surgical treatment.
About the Authors
D. V. Sidorov
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, head of the Department of Abdominal Oncology,
3, 2nd Botkinskiy proezd, Moscow, 125284
S. O. Stepanov
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
MD, Head of the Department of Ultrasound Diagnostics
Russian Federation
MD, Head of the Department of Ultrasound Diagnostics
M. V. Lozhkin
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
PhD, Leading Researcher, Department of Abdominal Oncology
Russian Federation
PhD, Leading Researcher, Department of Abdominal Oncology
L. O. Petrov
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
PhD, Senior Researcher, Department of Abdominal Oncology
Russian Federation
PhD, Senior Researcher, Department of Abdominal Oncology
O. V. Gutz
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
PhD, Senior Researcher, Department of Ultrasound Diagnostics
Russian Federation
PhD, Senior Researcher, Department of Ultrasound Diagnostics
A. A. Kostin
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD., Professor, Head of Department of Urology, Oncology and Radiology of FAS, Medical institute, Peoples Friendship University of Russia;
First Deputy General Director National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
A. G. Isaeva
P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation
Russian Federation
clinical resident of the Department of Abdominal Oncology
Russian Federation
clinical resident of the Department of Abdominal Oncology
References
1. Kaprin AD, Sidorov DV, Rubtsova NA, Leontyev AV, Lozhkin MV, Petrov LO, et al. Prediction and prevention of liver failure after major liver primary and metastatic tumors resection. Research’n Practical Medicine Journal. 2016; 3 (2): 13–21. (In Russian). DOI: 10.17709/2409–2231–2016–3-2–2
2. Sidorov DV, Rubtsova NA, Leontyev AV, Lozhkin MV, Petrov LO, Lazutina TN, et al. Methods of evaluation of the functional status of the liver in the planning of anatomical resections about primary and metastatic tumors: current state of the problem, their own experience and perspectives. Research’n Practical Medicine Journal. 2015; 2 (1): 13–20. (In Russian). DOI: 10.17709/2409–2231–2015–2-1–13–20
3. Gallagher DJ, Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology. 2010;78 (3–4):237–48. DOI: 10.1159/000315730
4. Di Costanzo GG, D’Adamo G, Tortora R, Zanfardino F, Mattera S, Francica G, Pacella CM. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol. 2013 Oct;54 (8):876–81. DOI: 10.1177/0284185113489825
5. Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Effectiveness, Safety, and Local Progression After Percutaneous Laser Ablation for Hepatocellular Carcinoma Nodules up to 4 cm Are Not Affected by Tumor Location. AJR Am J Roentgenol. 2012 Dec;199 (6):1393–401. DOI: 10.2214/AJR.11.7850
6. Pacella CM, Bizzarri G, Francica G, Forlini G, Petrolati A, Valle D, et al. Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation. J Hepatol. 2006 May; 44 (5): 902–9. DOI: 10.1016/j.jhep.2006.01.031
Review
For citations:
Sidorov D.V., Stepanov S.O., Lozhkin M.V., Petrov L.O., Gutz O.V., Kostin A.A., Isaeva A.G. FIRST RUSSIAN EXPERIENCE OF USING THE INTEGRATED SYSTEM OF LASER THERMOABLATION THERAPY IN THE TREATMENT OF METASTATIC LIVER CANCER. Research and Practical Medicine Journal. 2017;4(3):100-107. (In Russ.) https://doi.org/10.17709/2409-2231-2017-4-3-10
Views:
1052
Email this article 